Arecor Ltd

@arecor_ltd

Biopharmaceutical company transforming patient care by bringing innovative medicines to market.

Cambridge UK
Vrijeme pridruživanja: svibanj 2011.

Tweetovi

Blokirali ste korisnika/cu @arecor_ltd

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @arecor_ltd

  1. proslijedio/la je Tweet

    Chesterford is home to innovative & organisations ranging from start-ups to large multinational corporations. Scientists, inventors & entrepreneurs work side by side making a real difference. Discover our current occupiers:

    Poništi
  2. 24. sij

    Don't miss Dr Jezek's presentation today at 10:05 PST

    Poništi
  3. proslijedio/la je Tweet
    17. sij
    Odgovor korisnicima i sljedećem broju korisnika:

    Worth noting too that Arecor CEO, Sarah Howell is on the "People" list, along with 's and 's who all have their companies in !

    Poništi
  4. 16. sij

    We are very excited to announce we have been longlisted for the

    Poništi
  5. proslijedio/la je Tweet
    16. sij
    Poništi
  6. 16. sij

    Dr Jezek's presentation at on 24 Jan at 10:05, 'Controlling Aggregation of a Range of Novel Biopharmaceutical Product Modalities’, summarises case studies demonstrating the capability of our formulation technology platform, Arestat™.

    Poništi
  7. proslijedio/la je Tweet
    9. sij

    Proud to be working with to develop a new, ready-to-use medicine. This is another important step forward for Hikma in developing and commercialising complex medicines and delivery systems that benefit patients.

    Poništi
  8. 9. sij

    We are delighted to announce an exclusive agreement between Hikma and Arecor to develop and commercialise ready-to-use medicine using Arestat™ technology. Visit our website to find out more

    Poništi
  9. 6. pro 2019.

    A great place to work and to hold meetings.

    Poništi
  10. 5. pro 2019.

    We're delighted to announce positive headline results for the first phase I clinical trial of AT247, a novel ultra rapid acting formulation of insulin. See our website for more details...

    Poništi
  11. 3. pro 2019.

    Arecor is delighted to announce our CEO, Dr Sarah Howell, has been nominated as one of the people on 's list

    Poništi
  12. 22. stu 2019.

    Great to hear one of our investors highlighting Arecor as a key part of their portfolio

    Poništi
  13. 21. stu 2019.

    Arecor is proud to be part of ELITE’s Future Shapers Report, showcasing some of the most ambitious, innovative and disruptive companies within the ELITE network.

    Poništi
  14. 18. stu 2019.

    We're excited to announce our CEO, Dr Sarah Howell, will present at the 6th China Healthcare Summit, tomorrow at 14:50 in Shanghai. Hosted by & . Learn more about Arecor here

    Poništi
  15. 21. ruj 2015.

    Arecor vacancy: Business Development Administrator. Please email info@arecor.com/call 01223 426060

    Poništi
  16. 31. srp 2014.

    PRESS RELEASE: awarded prestigious TSB Grant to Support Expanded Protein Stability Platform -

    Poništi
  17. 23. lip 2014.

    GALVmed-Arecor Collaboration: Innovative Vaccine Formulations for Developing World Livestock -

    Poništi
  18. 23. lip 2014.

    CPI Collaborate With Arecor To Enhance The Compatibility Of Biologic Medicines With Containers

    Poništi
  19. 8. svi 2014.

    Arecor featured in GEN Corporate Profile: Arecor Employs Excipients for Biologics Stability

    Poništi
  20. proslijedio/la je Tweet
    21. ožu 2014.

    . presents data for Arestat™ formulation technology

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·